31
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The impact of immunization programs on 10 vaccine preventable diseases in Italy: 1900-2015.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Vaccination has determined a dramatic decline in morbidity and mortality from infectious diseases over the last century. However, low perceived risk of the infectious threat and increased concern about vaccines' safety led to a reduction in vaccine coverage, with increased risk of disease outbreaks.

          Related collections

          Author and article information

          Journal
          Vaccine
          Vaccine
          Elsevier BV
          1873-2518
          0264-410X
          March 07 2018
          : 36
          : 11
          Affiliations
          [1 ] Department of Infectious Diseases, Istituto Superiore di Sanità (Italian National Institute of Health), Rome, Italy. Electronic address: patrizio.pezzotti@iss.it.
          [2 ] Department of Infectious Diseases, Istituto Superiore di Sanità (Italian National Institute of Health), Rome, Italy.
          [3 ] Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.
          [4 ] National Center of Health Technology Assessment, Istituto Superiore di Sanità, Rome, Italy.
          [5 ] Department of Economics, Roma Tre University, Rome, Italy.
          [6 ] Istituto Superiore di Sanità, Rome, Italy; Institute of Hygiene and Public Health, Catholic University of the Sacred Heart, Rome, Italy.
          Article
          S0264-410X(18)30126-9
          10.1016/j.vaccine.2018.01.065
          29428176
          5a98c51f-0feb-4c80-8636-a358867eb680
          History

          Mortality,Prevention,Surveillance,Vaccines,ARIMA models,Morbidity

          Comments

          Comment on this article